Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

The role of Syk in peripheral T cells.

Park JE, Majumdar S, Brand DD, Rosloniec EF, Yi AK, Stuart JM, Kang AH, Myers LK.

Clin Immunol. 2018 Jul;192:50-57. doi: 10.1016/j.clim.2018.04.007. Epub 2018 Apr 16.

2.

Retinal Vasculitis and Choroidopathy in Pediatric-Onset Mixed Connective Tissue Disease.

Postlethwaite B, Wynn HG, Pattanaik D, Ost S, MacDonald CB, Walton RC, Kim S, Myers LK, Brown Lobbins M.

J Clin Rheumatol. 2017 Oct;23(7):400-401. doi: 10.1097/RHU.0000000000000591. No abstract available.

3.

The Role of Leukocyte-Associated Ig-like Receptor-1 in Suppressing Collagen-Induced Arthritis.

Kim S, Easterling ER, Price LC, Smith SL, Coligan JE, Park JE, Brand DD, Rosloniec EF, Stuart JM, Kang AH, Myers LK.

J Immunol. 2017 Oct 15;199(8):2692-2700. doi: 10.4049/jimmunol.1700271. Epub 2017 Sep 8.

4.

Characterization of the Syk-Dependent T Cell Signaling Response to an Altered Peptide.

Park JE, Rotondo JA, Cullins DL, Brand DD, Yi AK, Stuart JM, Kang AH, Myers LK.

J Immunol. 2016 Dec 15;197(12):4569-4575. Epub 2016 Nov 11.

5.

Application of neuroplasticity theory through the use of the Feldenkrais Method(®) with a runner with scoliosis and hip and lumbar pain: A case report.

Myers LK.

J Bodyw Mov Ther. 2016 Apr;20(2):300-9. doi: 10.1016/j.jbmt.2015.06.003. Epub 2015 Jun 9.

PMID:
27210847
6.

Synthesis and Biological Evaluation of Vitamin D3 Metabolite 20S,23S-Dihydroxyvitamin D3 and Its 23R Epimer.

Lin Z, Marepally SR, Ma D, Kim TK, Oak AS, Myers LK, Tuckey RC, Slominski AT, Miller DD, Li W.

J Med Chem. 2016 May 26;59(10):5102-8. doi: 10.1021/acs.jmedchem.6b00182. Epub 2016 Apr 22.

7.

Design, Synthesis and Biological Activities of Novel Gemini 20S-Hydroxyvitamin D3 Analogs.

Lin Z, Marepally SR, Kim TK, Janjetovic Z, Oak AS, Postlethwaite AE, Myers LK, Tuckey RC, Slominski AT, Miller DD, Li W.

Anticancer Res. 2016 Mar;36(3):877-86.

8.

Chemical Synthesis and Biological Activities of 20S,24S/R-Dihydroxyvitamin D3 Epimers and Their 1α-Hydroxyl Derivatives.

Lin Z, Marepally SR, Ma D, Myers LK, Postlethwaite AE, Tuckey RC, Cheng CY, Kim TK, Yue J, Slominski AT, Miller DD, Li W.

J Med Chem. 2015 Oct 8;58(19):7881-7. doi: 10.1021/acs.jmedchem.5b00881. Epub 2015 Sep 28.

9.

Role of the neutrophil chemorepellent soluble dipeptidyl peptidase IV in decreasing inflammation in a murine model of arthritis.

Herlihy SE, Brown ML, Pilling D, Weeks BR, Myers LK, Gomer RH.

Arthritis Rheumatol. 2015 Oct;67(10):2634-8. doi: 10.1002/art.39250.

10.

Peptide ligand structure and I-Aq binding avidity influence T cell signaling pathway utilization.

Myers LK, Cullins DL, Park JE, Yi AK, Brand DD, Rosloniec EF, Stuart JM, Kang AH.

Clin Immunol. 2015 Oct;160(2):188-97. doi: 10.1016/j.clim.2015.05.002. Epub 2015 May 14.

11.

Function and regulation of self-reactive marginal zone B cells in autoimmune arthritis.

Palm AK, Friedrich HC, Mezger A, Salomonsson M, Myers LK, Kleinau S.

Cell Mol Immunol. 2015 Jul;12(4):493-504. doi: 10.1038/cmi.2015.37. Epub 2015 May 11.

12.

Characterization of T cell phenotype and function in a double transgenic (collagen-specific TCR/HLA-DR1) humanized model of arthritis.

Tang B, Kim S, Hammond S, Cullins DL, Brand DD, Rosloniec EF, Stuart JM, Postlethwaite AE, Kang AH, Myers LK.

Arthritis Res Ther. 2014 Jan 10;16(1):R7. doi: 10.1186/ar4433.

13.

A 9-year-old boy with chronic urticaria and progressive spondyloarthritis.

Park D, Brown ML, Densen P, Myers LK, Lew DB.

Allergy Asthma Proc. 2013 Jan-Feb;34(1):103-7. doi: 10.2500/aap.2013.34.3617.

PMID:
23406943
14.

Characterization of inhibitory T cells induced by an analog of type II collagen in an HLA-DR1 humanized mouse model of autoimmune arthritis.

Kimata M, Cullins DL, Brown ML, Brand DD, Rosloniec EF, Myers LK, Stuart JM, Kang AH.

Arthritis Res Ther. 2012 May 8;14(3):R107. doi: 10.1186/ar3832.

15.

Molecular basis for T cell response induced by altered peptide ligand of type II collagen.

Park JE, Cullins D, Zalduondo L, Barnett SL, Yi AK, Kleinau S, Stuart JM, Kang AH, Myers LK.

J Biol Chem. 2012 Jun 1;287(23):19765-74. doi: 10.1074/jbc.M112.349688. Epub 2012 Apr 16.

16.

A fatal presentation of dermatomyositis with facial swelling.

Dwivedi N, Michael C, Lew DB, Arnold S, Igarashi M, Bertorini T, Thompson JW, Myers LK, Brown ML.

Int J Pediatr Otorhinolaryngol. 2012 May;76(5):745-9. doi: 10.1016/j.ijporl.2012.01.037. Epub 2012 Feb 28.

PMID:
22376996
17.

Supernatants from culture of type I collagen-stimulated PBMC from patients with cutaneous systemic sclerosis versus localized scleroderma demonstrate suppression of MMP-1 by fibroblasts.

Brown M, Postlethwaite AE, Myers LK, Hasty KA.

Clin Rheumatol. 2012 Jun;31(6):973-81. doi: 10.1007/s10067-012-1962-z. Epub 2012 Feb 25.

18.

T cells stimulated with an analog peptide of type II collagen require the Fc receptor γ-chain to secrete interleukin-4 and suppress autoimmune arthritis in mice.

Myers LK, Cullins DL, Brand DD, Kleinau S, Stuart JM, Kang AH.

Arthritis Rheum. 2011 Sep;63(9):2661-70. doi: 10.1002/art.30454.

19.

Modulation of collagen-induced arthritis by adenovirus-mediated intra-articular expression of modified collagen type II.

Tang B, Cullins DL, Zhou J, Zawaski JA, Park H, Brand DD, Hasty KA, Gaber MW, Stuart JM, Kang AH, Myers LK.

Arthritis Res Ther. 2010;12(4):R136. doi: 10.1186/ar3074. Epub 2010 Jul 8.

20.

Collagen-induced arthritis.

Rosloniec EF, Cremer M, Kang AH, Myers LK, Brand DD.

Curr Protoc Immunol. 2010 Apr;Chapter 15:Unit 15.5.1-25. doi: 10.1002/0471142735.im1505s89.

PMID:
20376842
21.

T cell receptor signaling induced by an analog peptide of type II collagen requires activation of Syk.

Tang B, Zhou J, Park JE, Cullins D, Yi AK, Kang AH, Stuart JM, Myers LK.

Clin Immunol. 2009 Oct;133(1):145-53. doi: 10.1016/j.clim.2009.06.006.

22.

46,X,del(X)(q13) Turner's syndrome women with systemic lupus erythematosus in a pedigree multiplex for SLE.

Cooney CM, Bruner GR, Aberle T, Namjou-Khales B, Myers LK, Feo L, Li S, D'Souza A, Ramirez A, Harley JB, Scofield RH.

Genes Immun. 2009 Jul;10(5):478-81. doi: 10.1038/gene.2009.37. Epub 2009 May 21.

23.

Fever and rash.

Brown ML, Chesney PJ, Ault BH, Delos Santos NM, Truong LD, Lohr KM, Myers LK.

Clin Pediatr (Phila). 2008 Jul;47(6):610-4. doi: 10.1177/0009922807312727. No abstract available.

PMID:
18566359
24.

Collagen-induced arthritis.

Rosloniec EF, Cremer M, Kang A, Myers LK.

Curr Protoc Immunol. 2001 May;Chapter 15:Unit 15.5. doi: 10.1002/0471142735.im1505s20.

PMID:
18432737
25.

An altered peptide ligand of type II collagen suppresses autoimmune arthritis.

Myers LK, Tang B, Rosioniec EF, Stuart JM, Kang AH.

Crit Rev Immunol. 2007;27(4):345-56.

PMID:
18197813
26.

The effects of interleukin-18 on rat articular chondrocytes: a study of mRNA expression and protein synthesis of proinflammatory substances.

Ye XJ, Tang B, Ma Z, Zhou J, Myers LK, Kang AH, Cremer MA.

Clin Exp Immunol. 2007 Sep;149(3):553-60. Epub 2007 Jul 10.

27.

Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.

Sakurai Y, Brand DD, Tang B, Rosloniec EF, Stuart JM, Kang AH, Myers LK.

Arthritis Res Ther. 2006;8(5):R150.

28.

The isozyme-specific effects of cyclooxygenase-deficiency on bone in mice.

Myers LK, Bhattacharya SD, Herring PA, Xing Z, Goorha S, Smith RA, Bhattacharya SK, Carbone L, Faccio R, Kang AH, Ballou LR.

Bone. 2006 Nov;39(5):1048-1052. doi: 10.1016/j.bone.2006.05.015. Epub 2006 Jul 27.

PMID:
16875891
29.

Bone mineral density and turnover in non-corticosteroid treated African American children with juvenile rheumatoid arthritis.

Head AJ, Myers LK, Watsky MA, Greenwell MW, Barrow KD, Michelson JA, Carbone LD.

J Rheumatol. 2006 May;33(5):1001-3.

PMID:
16652430
30.

Treatment of murine collagen-induced arthritis by the stress protein BiP via interleukin-4-producing regulatory T cells: a novel function for an ancient protein.

Brownlie RJ, Myers LK, Wooley PH, Corrigall VM, Bodman-Smith MD, Panayi GS, Thompson SJ.

Arthritis Rheum. 2006 Mar;54(3):854-63.

31.

Molecular characterization of an arthritogenic collagen peptide interacting with I-Ar.

Sakurai Y, Tang B, Rosloniec EF, Stuart JM, Kang AH, Myers LK.

Immunology. 2006 Jan;117(1):136-42.

32.

Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice.

Mukherjee P, Yang SY, Wu B, Song Z, Myers LK, Robbins PD, Wooley PH.

Ann Rheum Dis. 2005 Nov;64(11):1550-6. Epub 2005 Apr 28.

33.

Hyperparathyroidism and the calcium paradox of aldosteronism.

Chhokar VS, Sun Y, Bhattacharya SK, Ahokas RA, Myers LK, Xing Z, Smith RA, Gerling IC, Weber KT.

Circulation. 2005 Feb 22;111(7):871-8. Epub 2005 Feb 14.

PMID:
15710759
34.

Disseminated blastomycosis presenting as oligoarticular septic arthritis in a 12-year-old girl.

Head AJ, Myers LK, Thompson JD, Buckingham SC, Skinner RB Jr.

Arthritis Rheum. 2005 Feb 15;53(1):138-41. No abstract available.

35.

Pathogenesis of collagen-induced arthritis: modulation of disease by arthritogenic T-cell epitope location.

Tang B, Brand DD, Ma Z, Stuart JM, Myers LK, Kang AH.

Immunology. 2004 Nov;113(3):384-91.

36.

Loss of bone minerals and strength in rats with aldosteronism.

Chhokar VS, Sun Y, Bhattacharya SK, Ahokas RA, Myers LK, Xing Z, Smith RA, Gerling IC, Weber KT.

Am J Physiol Heart Circ Physiol. 2004 Nov;287(5):H2023-6.

37.

Efficacy of modified recombinant type II collagen in modulating autoimmune arthritis.

Myers LK, Tang B, Brand DD, Rosloniec EF, Stuart JM, Kang AH.

Arthritis Rheum. 2004 Sep;50(9):3004-11.

38.
39.

T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage.

He X, Rosloniec EF, Myers LK, McColgan WL 3rd, Gumanovskaya M, Kang AH, Stuart JM.

Arthritis Rheum. 2004 Jun;50(6):1996-2004.

40.

The roles of interleukin-18 in collagen-induced arthritis in the BB rat.

Ye XJ, Tang B, Ma Z, Kang AH, Myers LK, Cremer MA.

Clin Exp Immunol. 2004 Jun;136(3):440-7.

41.

An analog peptide that suppresses collagen-induced arthritis.

Myers LK, Sakurai Y, Rosloniec EF, Stuart JM, Kang AH.

Am J Med Sci. 2004 Apr;327(4):212-6.

PMID:
15084917
42.

Relevance of posttranslational modifications for the arthritogenicity of type II collagen.

Myers LK, Myllyharju J, Nokelainen M, Brand DD, Cremer MA, Stuart JM, Bodo M, Kivirikko KI, Kang AH.

J Immunol. 2004 Mar 1;172(5):2970-5.

43.

Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis.

Bowyer SL, Roettcher PA, Higgins GC, Adams B, Myers LK, Wallace C, Rennebohm R, Moore TL, Pepmueller PH, Spencer C, Wagner-Weiner L, Rabinovich E, Passo M, Lovell DJ, McCurdy D, Zemel L, Schikler KN, Szer I, Kurtin P, Lindsley C.

J Rheumatol. 2003 Feb;30(2):394-400.

PMID:
12563701
44.

Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.

Myers LK, Sakurai Y, Tang B, He X, Rosloniec EF, Stuart JM, Kang AH.

Arthritis Rheum. 2002 Dec;46(12):3369-77.

45.

Amelioration of relapsing polychondritis in a child treated with oral collagen.

Navarro MJ, Higgins GC, Lohr KM, Myers LK.

Am J Med Sci. 2002 Aug;324(2):101-3.

PMID:
12187928
46.

Immunogenicity of recombinant type IX collagen in murine collagen-induced arthritis.

Myers LK, Pihlajamaa T, Brand DD, Cremer MA, Bodo M, Ala-Kokko L, Kang AH.

Arthritis Rheum. 2002 Apr;46(4):1086-93.

47.

A single-chain class II MHC-IgG3 fusion protein inhibits autoimmune arthritis by induction of antigen-specific hyporesponsiveness.

Zuo L, Cullen CM, DeLay ML, Thornton S, Myers LK, Rosloniec EF, Boivin GP, Hirsch R.

J Immunol. 2002 Mar 1;168(5):2554-9.

48.

The role of IL-4 in regulation of murine collagen-induced arthritis.

Myers LK, Tang B, Stuart JM, Kang AH.

Clin Immunol. 2002 Feb;102(2):185-91.

PMID:
11846461
49.

An enzyme hydrolyzing methylated inhibitors of nitric oxide synthase is present in circulating human red blood cells.

Kang ES, Cates TB, Harper DN, Chiang TM, Myers LK, Acchiardo SR, Kimoto M.

Free Radic Res. 2001 Dec;35(6):693-707.

PMID:
11811522
50.

Detection of early changes in autoimmune T cell phenotype and function following intravenous administration of type II collagen in a TCR-transgenic model.

Brand DD, Myers LK, Whittington KB, Latham KA, Stuart JM, Kang AH, Rosloniec EF.

J Immunol. 2002 Jan 1;168(1):490-8.

Supplemental Content

Loading ...
Support Center